News & Events

Eugene Goldenberg Joins Edgemont Partners as Managing Director to Lead its Investment Banking Franchise in Post-Acute Services, Distribution and Staffing

Press Release

NEW YORK, NY — January 7, 2020 — Edgemont Partners, a leading independent healthcare-focused investment banking firm, is pleased to announce that Eugene Goldenberg has joined the firm as Managing Director to build and lead its investment banking franchise in post-acute services, distribution and staffing.

Mr. Goldenberg brings deep knowledge of corporate finance and proven advisory expertise from 15 years of experience advising both public and private companies in a variety of merger and acquisition, capital raising and strategic transactions. Since 2012, he has executed over 25 healthcare transactions representing more than $6 billion in aggregate value.

Mr. Goldenberg joins Edgemont from the Corporate M&A Advisory practice at Cain Brothers, where he grew the firm’s nascent post-acute business into a preeminent home health and hospice franchise. Prior to Cain Brothers, Eugene worked as a senior equity research analyst at BB&T Capital Markets, where he focused on small and mid-cap healthcare services companies in home health and hospice, pharmacy benefit management (PBMs), distribution, specialty pharmacy and infusion, healthcare technology (HCIT) and care management. He started his career at Morgan Stanley. Mr. Goldenberg earned a Bachelor of Science from Rutgers University with a Major in Finance and a Minor in Art History.

Mr. Goldenberg will lead Edgemont’s highly-regarded team of investment banking professionals in advising post-acute (home health, hospice, personal care and chronic care management), distribution (direct-to-consumer and business-to-business) and staffing (autism, education, travel nurse, locum tenens, allied, and per diem) companies.

“Eugene’s expertise extends Edgemont’s exclusive healthcare industry focused coverage to these additional large and active verticals. His extensive M&A advisory experience and intimate sector knowledge will provide tremendous value to our investment banking clients,” said David Blume, Co-founder of Edgemont Partners. “Eugene’s focus builds upon Edgemont’s 18-year history advising best-in-class healthcare companies and he is a great addition to our team.”

“We are excited to welcome Eugene to Edgemont,” said Jeff Swearingen, Co-founder of Edgemont Partners. “Eugene’s experience, relationships and deep expertise across both healthcare and staffing is a unique skill set and expands the high value-added capabilities that distinguishes Edgemont as a leading healthcare investment bank. We look forward to his contributions as we continue to scale the Firm.”

“Edgemont is a rapidly growing and well-respected healthcare M&A advisory firm,” said Mr. Goldenberg. “I am excited to join this talented team, helping to broaden the franchise into the post-acute, distribution and staffing sub-sectors of healthcare services.”

Eugene will be based in New York alongside the rest of the Edgemont team.

With 30+ professionals, Edgemont Partners is one of the largest healthcare-dedicated investment banking teams. The Firm has executed over 155 healthcare and life sciences transactions.

About Edgemont Partners
Edgemont Partners is a premier investment bank that provides merger and acquisition advisory
and growth capital raising services exclusively to healthcare companies. We focus solely on
providing expert strategic advice and transaction execution, bringing a steadfast commitment to our clients, driven always by what’s in their best interest. This dedication enables us to deliver independent conflict-free advice, to serve as trusted advisors to healthcare entrepreneurs, management teams and investors, and to execute with exceptional results. For more information on Edgemont and how we can best serve you, contact Ben Hughes at (646) 632-3967 or visit our website at www.edgemont.com.

Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member of FINRA and SIPC.